Gulf International Bank (Uk) LTD Ionis Pharmaceuticals Inc Transaction History

Gulf International Bank (Uk) LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$34.54 - $47.25 $826,887 - $1.13 Million	-23,940 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $402,144 - $603,358	-9,460 Reduced 28.32%	23,940 $1.08 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $1.51 Million - $2.01 Million	33,400 New	33,400 $1.89 Million

414

136M

862K

617K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.63B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.